An interventional study of Local Myofascial Release and Superficial Back Line Myofascial Release in Chronic Low-back Pain (cLBP), sponsored by Kirsehir Ahi Evran Universitesi. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-04.
Sponsored by Kirsehir Ahi Evran Universitesi · Not applicable, Interventional, and Treatment
Participants with chronic low back pain will be randomly allocated to three groups: conservative treatment, conservative treatment plus local myofascial release, or conservative treatment plus superficial back line myofascial release. All groups will receive treatment three times weekly for six weeks. The conservative treatment program will include stretching, strengthening, and postural exercises. Myofascial release will be performed using a roller bar, with controlled rhythmic pressure applied for 30-60 seconds per region, totaling 10-15 minutes per session, according to individual tolerance. Age, height, weight, and body mass index will be recorded. Outcomes will include pain intensity (Visual Analog Scale), pressure pain threshold (digital algometer), range of motion (goniometer), static and dynamic balance (Biodex Balance System), and functional disability (Oswestry Disability Index). All outcomes will be assessed before and after the intervention.
Chronic low back pain is a common musculoskeletal condition that can negatively affect physical function, postural control, mobility, and quality of life. In addition to conventional exercise-based interventions, myofascial release techniques have been used to address soft tissue restrictions and improve musculoskeletal function. However, the effects of applying myofascial release locally to the lumbar region compared with applying it along the Superficial Back Line have not been sufficiently clarified in individuals with chronic low back pain.
The aim of this study is to investigate and compare the effects of local lumbar myofascial release and Superficial Back Line myofascial release, when combined with conservative treatment, on pain intensity, pressure pain threshold, lumbar range of motion, static and dynamic balance, and functional disability in individuals with chronic low back pain.
Participants diagnosed with chronic low back pain will be randomly allocated to one of three intervention groups: (1) conservative treatment alone, (2) conservative treatment combined with local lumbar myofascial release, and (3) conservative treatment combined with myofascial release applied along the Superficial Back Line. All interventions will be administered three times per week for six consecutive weeks, resulting in a total of 18 treatment sessions.
The conservative treatment program will be applied to all three groups and will consist of stretching, strengthening, and postural exercises designed to address the physical limitations associated with chronic low back pain. Participants in the second group will additionally receive local myofascial release targeting the lumbar region. Participants in the third group will receive myofascial release along the Superficial Back Line, targeting the posterior myofascial structures according to the intervention protocol.
Myofascial release will be performed using a roller bar. Controlled and rhythmic pressure will be applied for approximately 60 seconds per treatment region. The total duration of the myofascial release application will be approximately 10-15 minutes per session, depending on the treatment protocol and individual participant tolerance.
Demographic and anthropometric characteristics, including age, height, and body weight, will be recorded, and body mass index will be calculated.
Clinical outcomes will be evaluated before and after the six-week intervention period. Pain intensity will be assessed using the Visual Analog Scale (VAS), while pressure pain threshold will be measured using a digital algometer. Lumbar range of motion will be evaluated using a goniometer. Static and dynamic balance will be assessed using the Biodex Balance System. Functional disability related to low back pain will be evaluated using the Oswestry Disability Index (ODI).
The changes in clinical outcomes within each group and the differences between the three intervention groups will be analyzed to determine whether adding local lumbar myofascial release or Superficial Back Line myofascial release to conservative treatment provides additional benefits. The study will also compare the effects of the two myofascial approaches to determine whether the location and extent of myofascial application influence clinical outcomes in individuals with chronic low back pain.
2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.
This study's planned enrollment of 60 is close to the median of 60 across 2,364 interventional studies indexed under Low Back Pain.
Browse Low Back Pain studies →Kirsehir Ahi Evran Universitesi is the lead sponsor of 138 studies on the registry; 52 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients attended treatment sessions specifically for low back pain, receiving conservative treatment as indicated.
Other: Conservative treatment
Myofascial release targeting only the lumbar region will be performed in addition to conservative treatment.
Device: Local Myofascial Release · Other: Conservative treatment
Myofascial release will be applied along the entire superficial back line in addition to conservative treatment.
Device: Superficial Back Line Myofascial Release · Other: Conservative treatment
Myofascial release targeting only the lumbar region will be performed in addition to conservative treatment.
Myofascial release will be applied along the entire superficial back line in addition to conservative treatment.
Patients attended treatment sessions specifically for low back pain, receiving conservative treatment as indicated.
Change in Pain Intensity from Baseline to Week 6
Pain intensity will be assessed using the Visual Analog Scale (VAS). Participants will rate their pain intensity on a 10-cm line, with 0 indicating no pain and 10 indicating the worst imaginable pain. The change in pain intensity from baseline to the end of the intervention will be evaluated.
Time frame: Baseline and Week 6
Change in Balance Performance from Baseline to Week 6
Balance performance will be assessed using \[Biodex Blance System\]. Changes in balance performance from baseline to the end of the intervention will be evaluated.
Time frame: Baseline and Week 6
Change in Functional Disability from Baseline to Week 6
Functional disability will be assessed using \[Oswerty Disability Index\]. Changes in functional disability scores from baseline to the end of the intervention will be evaluated.
Time frame: Baseline and Week 6
Change in Lumbar Range of Motion from Baseline to Week 6
Lumbar range of motion will be assessed using \[goniometer\]. Changes in lumbar range of motion from baseline to the end of the intervention will be evaluated in degrees.
Time frame: Baseline and Week 6
No study locations are listed for this record.
Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.
Of 1,231 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 2 months is below that.
Counting every sponsor, half of 1,286 studies reached it within 11 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kirsehir Ahi Evran Universitesi →